| Current Price | $158.02 | Mkt Cap | $278.8B |
|---|---|---|---|
| Open | $155.28 | P/E Ratio | 22.55 |
| Prev. Close | $158.02 | Div. (Yield) | $5.92 (3.7%) |
| Daily Range | $154.59 - $158.48 | Volume | 4,678,822 |
| 52-Wk Range | $134.09 - $175.91 | Avg. Daily Vol. | 6,656,464 |
| Current Price | $158.02 | Mkt Cap | $278.8B |
|---|---|---|---|
| Open | $155.28 | P/E Ratio | 22.55 |
| Prev. Close | $158.02 | Div. (Yield) | $5.92 (3.7%) |
| Daily Range | $154.59 - $158.48 | Volume | 4,678,822 |
| 52-Wk Range | $134.09 - $175.91 | Avg. Daily Vol. | 6,656,464 |
The best Bull and Bear pitches based on recency and number of recommendations.
This mega-cap has made a big run since Express Scripts's announcement that it will take AbbVie's hep C treatment in lieu of Gilead's. Also, an amazing preponderance of CAPS bulls favor this stock beating the market from here -- very interesting. For… More
Read the most recent pitches from players about ABBV.
Recs
CellBlock9
(72.83)
Submitted: 8/16/2022 9:51:10 PM :
Start Price:
$139.98
NYSE:ABBV Score:
+20.15
zk
Recs
1russianguy
(81.75)
Submitted: 6/29/2022 3:30:45 PM :
Start Price:
$76.02
NYSE:ABBV Score:
+71.98
Can thrive during recession.
Recs
TMFWordman5150
(44.21)
Submitted: 2/17/2022 12:04:57 PM :
Start Price:
$140.98
NYSE:ABBV Score:
+22.54
Earnings Growth; a solid dividend of $5.64 per share; and a Pharma manufact. market with a CAGR of 11.34% through 2028.
Find the members with the highest scoring picks in ABBV.
armydave (55.34) Score: +429.90
The Score Leader is the player with the highest score across all their picks in ABBV.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| armydave | 55.34 |
|
|
5Y | $22.61 | +599.33% | +169.43% | +429.90 | 0 Comment | |
| pirotta | < 20 | 1/10/2013 |
|
5Y | $22.61 | +599.33% | +169.43% | +429.90 | 0 Comment | |
| deliman723 | 64.15 | 1/10/2013 |
|
5Y | $22.61 | +599.33% | +169.43% | +429.90 | 0 Comment | |
| concealedweaponR | < 20 | 1/10/2013 |
|
5Y | $22.61 | +599.33% | +169.43% | +429.90 | 0 Comment | |
| drjohn432 | < 20 |
|
|
5Y | $22.61 | +599.33% | +169.43% | +429.90 | 0 Comment | |
|
valari25 | 99.67 |
|
|
5Y | $22.61 | +599.33% | +169.43% | +429.90 | 0 Comment |
|
|
GW1000 | 86.66 |
|
|
5Y | $22.61 | +599.33% | +169.43% | +429.90 | 0 Comment |
|
|
mattmmurphy | 72.30 | 1/10/2013 |
|
5Y | $22.61 | +599.33% | +169.43% | +429.90 | 0 Comment |
| cooleyly | 55.67 | 1/10/2013 |
|
5Y | $22.61 | +599.33% | +169.43% | +429.90 | 0 Comment | |
|
|
kinosternon | 98.22 | 1/9/2013 |
|
5Y | $22.72 | +596.15% | +170.68% | +425.47 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
